UB Paderborn / Katalog / Suche / Details

The New England journal of medicine, 2021-02, Vol.384 (8), p.693-704

2021

Autor(en) / Beteiligte

Titel

Dexamethasone in Hospitalized Patients with Covid-19

Ist Teil von

Ort / Verlag

United States: Massachusetts Medical Society

Erscheinungsjahr

2021

Link zum Volltext

Quelle

Electronic Journals Library

Beschreibungen/Notizen

Among hospitalized patients with Covid-19, treatment with dexamethasone resulted in lower 28-day mortality than usual care, according to the level of respiratory support the patients were receiving, indicating a possible correlation between efficacy and the stage of infection.

Sprache: Englisch
Identifikatoren: ISSN: 0028-4793
eISSN: 1533-4406
DOI: 10.1056/NEJMoa2021436
Titel-ID: cdi_mms_nejm_10_1056_NEJMoa2021436

Format: –
Schlagworte: Administration, Oral, Aged, Aged, 80 and over, Anti-Infective Agents - therapeutic use, Care and treatment, Coronaviruses, COVID-19, COVID-19 - mortality, COVID-19 - therapy, COVID-19 Drug Treatment, Dexamethasone, Dexamethasone - administration & dosage, Dexamethasone - adverse effects, Dexamethasone - therapeutic use, Drug Therapy, Combination, Fatalities, Female, Glucocorticoids, Glucocorticoids - administration & dosage, Glucocorticoids - adverse effects, Glucocorticoids - therapeutic use, Hospital patients, Hospitalization, Humans, Inflammation, Injections, Intravenous, Intravenous administration, Kaplan-Meier Estimate, Length of Stay, Male, Mechanical ventilation, Medical research, Mortality, Odds Ratio, Oxygen, Oxygen Inhalation Therapy, Respiration, Artificial, Respiratory failure, Steroids, Testing, United Kingdom

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX